Pfizer sells Capsugel to KKR; Ugene's al peptide drug delivery tech validated;

> Pfizer is selling its Capsugel drug-delivery business to KKR for $2.375 billion in cash, Pfizer announced Monday. Capsugel offers a variety of products, including liquid formulations as part of its Licaps Drug Delivery System. News

> Unigene Laboratories claims a Phase III trial has validated its oral peptide drug delivery technology. Item

> Amgen is looking for an executive director of drug delivery engineering in Thousand Oaks, CA. Job listing

> UK-based biotech companies Critical Pharmaceuticals and PolyTherics are collaborating on an injectable, sustained-release drug-delivery system. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.